PRESS RELEASE: Sixgill, LLC, the leader in sensor data services for governing IoE, today unveiled the next generation of its universal and highly scalable sensor data services platform, Sixgill Sense 2.0. Sense 2.0 provides vital capabilities...
NYS Entity Status
NYS Filing Date
MAY 10, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - NEXT GENERATION THERAPEUTICS LLC
Around the Web
- Sixgill®, LLC Launches Sense 2.0
By Business Wire - Thursday Oct 12, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Inside Maine's Exclusive Prouts Neck Community
Thursday Aug 10, 2017
Many of the 200 or so homes on this the rocky peninsula have been in the same families for generations.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]